Improving Cancer MDT performance in Western Sydney - three years' experience.

Behaviour change Cancer MDT Multidisciplinary team Quality improvement

Journal

BMC health services research
ISSN: 1472-6963
Titre abrégé: BMC Health Serv Res
Pays: England
ID NLM: 101088677

Informations de publication

Date de publication:
06 Mar 2021
Historique:
received: 15 10 2020
accepted: 22 02 2021
entrez: 7 3 2021
pubmed: 8 3 2021
medline: 15 5 2021
Statut: epublish

Résumé

While multidisciplinary teams (MDTs) are now considered an essential part of cancer care decision-making, how they perform varies widely. The authors hypothesised that a comprehensive, multipronged improvement program, and associated annual member survey, could strengthen MDT performance across a whole cancer service. The study comprised the introduction of a structured program, the Tumour Program Strengthening Initiative (TPSI) linked with an annual survey of member's perceptions of their performance. Three iterations of the survey have been completed (2017, 2018 and 2019). Generalised estimating equations (GEEs) were used to test for a difference in the proportion of positive survey responses between 2017 and 2019 adjusted for team clustering. Twelve teams participated in TPSI. One hundred twenty-nine, 118 and 146 members completed the survey in 2017, 2018 and 2019, respectively. Of the 17 questions that were asked in all three years, nine showed significant improvement and, of these, five were highly significant. Documenting consensus, developing Terms of Reference (TORs), establishing referral criteria and referring to clinical practice guidelines showed most improvement. Questions related to patient considerations, professional development and quality improvement (QI) activities showed no significant change. TPSI resulted in sustained and significant improvement. The MDT survey not only allowed MDT members to identify their strengths and weaknesses but also provided insights for management to flag priority areas for further support. Overall program improvement reflected the strengthening of the weakest teams as well as further improvement in highly performing MDTs. Importantly, the initiative has the potential to achieve behaviour change amongst clinicians.

Sections du résumé

BACKGROUND BACKGROUND
While multidisciplinary teams (MDTs) are now considered an essential part of cancer care decision-making, how they perform varies widely. The authors hypothesised that a comprehensive, multipronged improvement program, and associated annual member survey, could strengthen MDT performance across a whole cancer service.
METHODS METHODS
The study comprised the introduction of a structured program, the Tumour Program Strengthening Initiative (TPSI) linked with an annual survey of member's perceptions of their performance. Three iterations of the survey have been completed (2017, 2018 and 2019). Generalised estimating equations (GEEs) were used to test for a difference in the proportion of positive survey responses between 2017 and 2019 adjusted for team clustering.
RESULTS RESULTS
Twelve teams participated in TPSI. One hundred twenty-nine, 118 and 146 members completed the survey in 2017, 2018 and 2019, respectively. Of the 17 questions that were asked in all three years, nine showed significant improvement and, of these, five were highly significant. Documenting consensus, developing Terms of Reference (TORs), establishing referral criteria and referring to clinical practice guidelines showed most improvement. Questions related to patient considerations, professional development and quality improvement (QI) activities showed no significant change.
CONCLUSIONS CONCLUSIONS
TPSI resulted in sustained and significant improvement. The MDT survey not only allowed MDT members to identify their strengths and weaknesses but also provided insights for management to flag priority areas for further support. Overall program improvement reflected the strengthening of the weakest teams as well as further improvement in highly performing MDTs. Importantly, the initiative has the potential to achieve behaviour change amongst clinicians.

Identifiants

pubmed: 33676492
doi: 10.1186/s12913-021-06203-y
pii: 10.1186/s12913-021-06203-y
pmc: PMC7937192
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

203

Subventions

Organisme : The University of Sydney
ID : WIPS
Organisme : Cancer Institute NSW
ID : 2017/18_05_02(E17/16419)

Références

J Multidiscip Healthc. 2018 Jan 19;11:49-61
pubmed: 29403284
Ann Surg Oncol. 2011 Aug;18(8):2116-25
pubmed: 21442345
Int J Breast Cancer. 2011;2011:831605
pubmed: 22295234
Br J Cancer. 2005 Oct 31;93(9):977-8
pubmed: 16234818
Scand J Work Environ Health. 2000 Aug;26(4):363-7
pubmed: 10994804
Ann Surg Oncol. 2012 Dec;19(13):4019-27
pubmed: 22820934
Asia Pac J Clin Oncol. 2018 Feb;14(1):74-83
pubmed: 28949100
BMJ. 2012 Apr 26;344:e2718
pubmed: 22539013
Ann R Coll Surg Engl. 2007 Mar;89(2):113-7
pubmed: 17346401
Br J Cancer. 2011 Apr 12;104(8):1246-8
pubmed: 21448166
Br J Cancer. 1994 Aug;70(2):363-70
pubmed: 8054286
Dis Esophagus. 2006;19(3):164-71
pubmed: 16722993
BMC Health Serv Res. 2010 May 20;10:132
pubmed: 20482884
BMC Health Serv Res. 2014 Sep 08;14:377
pubmed: 25196248
Dis Esophagus. 2006;19(6):496-503
pubmed: 17069595
J Urol. 2014 Sep;192(3):891-8
pubmed: 24631109
J Am Coll Surg. 2013 Sep;217(3):412-20
pubmed: 23891067
J Oncol Pract. 2015 May;11(3):239-46
pubmed: 25873056
Int J Qual Health Care. 2016 Jun;28(3):332-8
pubmed: 27084499
Lung Cancer. 2008 Apr;60(1):14-21
pubmed: 18304687
Ann Thorac Surg. 2015 Nov;100(5):1834-8; discussion 1838
pubmed: 26276054
BMJ Open Qual. 2019 May 31;8(2):e000435
pubmed: 31259279
Ann Oncol. 2012 May;23(5):1293-1300
pubmed: 22015450

Auteurs

Lynleigh Evans (L)

Sydney West - Translational Cancer Research Centre, Western Sydney Local Health District, PO Box 533 Wentworthville, Sydney, NSW, 2145, Australia. Lynleigh.evans@health.nsw.gov.au.

Yiren Liu (Y)

Tumour Program Strengthening Initiative innovation manager (2019), Western Sydney Local Health District, Sydney, Australia.

Brendan Donovan (B)

Tumour Program Strengthening Initiative innovation manager (2018), Western Sydney Local Health District, Sydney, Australia.

Terence Kwan (T)

Faculty of Engineering and IT, University of Sydney, Sydney, Australia.

Karen Byth (K)

Research and Education Network, Western Sydney Local Health District, Sydney, Australia.

Paul Harnett (P)

Sydney West - Translational Cancer Research Centre, Western Sydney Local Health District, PO Box 533 Wentworthville, Sydney, NSW, 2145, Australia.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH